Skip to main content
. 2019 Sep 15;8(9):bio043570. doi: 10.1242/bio.043570

Fig. 1.

Fig. 1.

Expression profiles of HE4 in tissues, serum and urine in ovarian cancer. (A) qRT-PCR determination of the expression levels of HE4 in 51 ovarian cancer, 50 benign ovarian cancer and normal tissue samples. (B) Western blot analyses of the expression levels of HE4 in ovarian cancer, benign ovarian cancer and normal tissue samples. ELISA detection of 51 ovarian cancer, 50 patients with benign ovarian cancer and 20 healthy serum (C) and urine samples (D). *P<0.05.